DEC 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/227001

Contents of this Issue


Page 17 of 74

Optimize Care, Enhance Your Practice Care, Your Practice o Improve Lipid Secretions, Increase Comfort, Satisfy Patients Improve Secretions, Increase Comfor Comfort, Patients Recognize the Impact of Meibomian Gland Dysfunction, Seize the Opportunity "TearScience® gives us another weapon in our arsenal to treat dry eye and stabilize the tear flm. It has been gratifying to help patients frustrated with the results of traditional therapies." Alex Cohen, MD, PhD Dean McGee Eye Institute Oklahoma City, OK LipiFlow® is clinically proven and the only medical device indicated for Meibomian Gland Dysfunction (MGD) currently available. Visit tearscience.com for complete product and safety information. LipiFlow® and LipiView® are registered trademarks of TearScience®, Inc. Copyright - TearScience® - The Evaporative Dry Eye Experts. All rights reserved. 13-ADV-120 REV A

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - DEC 2013